Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement March 24, 2023 AutoBot News 0 Harm Reduction Therapeutics and Catalent have signed a commercial supply agreement for naloxone nasal spray to reverse opioid overdoses.
